Report
EUR 13.98 For Business Accounts Only

M3 sees a downgrade to Slightly Negative on account of less fundamental stars

The independent financial analyst theScreener just lowered the general evaluation of M3 (JP), active in the Internet industry. As regards its fundamental valuation, the title now shows 0 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date March 25, 2022, the closing price was JPY 4,435.00 and its target price was estimated at JPY 3,583.85.
Underlying
M3 Inc.

M3 is mainly engaged in the operation of medical-related Internet websites "MR-kun" and "m3.com" for health-care professional. Along with its affiliates, Co. operates in five business segments. Co. is engaged in the development and provision of marketing support services to medical professional, pharmaceutical companies, medical equipment companies and consumers; the provision of support services utilizing Co.'s support management system called "CapTool" for clinical researches; the provision of sales, marketing and support services as well as research services in overseas; and the development, sale and support of electronic health record system; and the consignment of sales and marketing.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch